Christopher Comstock, MD

Accuracy of the modality relies on high-quality imaging protocols, a grasp of imaging processing and display, and interpreter experience

Use of dynamic contrast-enhanced MRI to evaluate the breast is rapidly increasing despite the lack of established standards or clearly defined indications and limited randomized clinical trials. The superior sensitivity of MRI for invasive breast cancer has led to the proliferation of its use. Its variable specificity, however, has limited its utility.